| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
21,284 |
16,566 |
$5.14M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,577 |
6,653 |
$3.35M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,131 |
3,871 |
$2.46M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
13,822 |
12,175 |
$2.22M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
14,721 |
10,073 |
$1.28M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,399 |
1,758 |
$913K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,562 |
3,286 |
$878K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
22,544 |
5,790 |
$806K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
12,137 |
8,585 |
$726K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,733 |
1,510 |
$684K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
10,297 |
4,197 |
$658K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,332 |
1,462 |
$542K |
| 71045 |
Radiologic examination, chest; single view |
9,622 |
6,138 |
$378K |
| 80053 |
Comprehensive metabolic panel |
51,273 |
33,885 |
$377K |
| G0378 |
Hospital observation service, per hour |
6,479 |
2,605 |
$371K |
| 71046 |
Radiologic examination, chest; 2 views |
6,491 |
4,932 |
$327K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
7,919 |
2,860 |
$292K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
9,856 |
8,186 |
$286K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
45,555 |
36,372 |
$277K |
| 59025 |
Fetal non-stress test |
2,313 |
1,546 |
$261K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,424 |
2,217 |
$259K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
493 |
384 |
$239K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
4,984 |
4,457 |
$236K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,014 |
1,989 |
$215K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
908 |
393 |
$205K |
| 36415 |
Collection of venous blood by venipuncture |
56,343 |
28,363 |
$198K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,564 |
2,747 |
$183K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
610 |
361 |
$183K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
3,776 |
1,230 |
$179K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
10,009 |
5,651 |
$176K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,818 |
1,363 |
$173K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
654 |
486 |
$171K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,218 |
2,165 |
$167K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
5,775 |
2,309 |
$159K |
| 97161 |
|
2,815 |
1,956 |
$145K |
| 84443 |
Thyroid stimulating hormone (TSH) |
9,671 |
9,032 |
$131K |
| 96376 |
|
3,612 |
1,986 |
$129K |
| 97803 |
|
3,507 |
3,378 |
$124K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
4,160 |
3,267 |
$110K |
| 76830 |
Ultrasound, transvaginal |
786 |
743 |
$107K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
521 |
450 |
$105K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
315 |
292 |
$102K |
| 36600 |
|
6,105 |
3,146 |
$102K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
739 |
678 |
$90K |
| 80061 |
Lipid panel |
6,620 |
5,883 |
$82K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,402 |
1,182 |
$81K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,523 |
1,676 |
$79K |
| 73630 |
|
1,325 |
1,219 |
$75K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,233 |
1,302 |
$72K |
| 73610 |
|
1,120 |
1,031 |
$70K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,092 |
670 |
$68K |
| 73562 |
|
1,316 |
1,133 |
$67K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
124 |
65 |
$64K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,369 |
416 |
$64K |
| 74018 |
|
1,135 |
1,019 |
$58K |
| 43248 |
|
290 |
195 |
$55K |
| 82607 |
|
4,206 |
3,986 |
$53K |
| 72110 |
|
453 |
401 |
$51K |
| 87400 |
|
3,863 |
3,551 |
$51K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,419 |
2,079 |
$51K |
| 93017 |
|
291 |
254 |
$48K |
| 97162 |
|
898 |
681 |
$48K |
| 58661 |
|
21 |
13 |
$47K |
| 73030 |
|
824 |
639 |
$47K |
| 80305 |
|
7,157 |
6,395 |
$46K |
| J2704 |
Injection, propofol, 10 mg |
9,698 |
7,700 |
$46K |
| 84702 |
|
3,754 |
2,435 |
$46K |
| 84484 |
|
6,004 |
4,981 |
$43K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
313 |
298 |
$42K |
| 94060 |
|
446 |
262 |
$40K |
| 73130 |
|
752 |
649 |
$40K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,203 |
5,030 |
$39K |
| 82803 |
|
3,876 |
2,811 |
$39K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
7,316 |
6,118 |
$38K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,709 |
4,462 |
$38K |
| 86900 |
|
2,213 |
1,879 |
$38K |
| 82746 |
|
2,898 |
2,768 |
$35K |
| 47563 |
|
12 |
12 |
$35K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
393 |
379 |
$35K |
| 83735 |
|
7,751 |
5,916 |
$35K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
113 |
94 |
$34K |
| 97164 |
|
1,070 |
929 |
$33K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,174 |
3,515 |
$32K |
| 97802 |
|
411 |
399 |
$32K |
| 86140 |
|
12,286 |
10,336 |
$31K |
| 84439 |
|
3,882 |
3,654 |
$31K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
17,649 |
13,007 |
$31K |
| 58558 |
|
30 |
28 |
$31K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
11,209 |
8,915 |
$29K |
| 83690 |
|
7,470 |
6,395 |
$28K |
| 82728 |
|
2,437 |
2,258 |
$28K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
8,035 |
6,009 |
$27K |
| 78227 |
|
85 |
69 |
$27K |
| 87077 |
|
4,977 |
3,488 |
$27K |
| 96367 |
|
790 |
396 |
$26K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,203 |
3,039 |
$25K |
| 83880 |
|
1,318 |
1,182 |
$24K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,530 |
1,453 |
$24K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,765 |
1,473 |
$23K |
| 81025 |
|
6,226 |
5,324 |
$23K |
| 81001 |
|
11,463 |
9,961 |
$23K |
| 84403 |
|
1,006 |
902 |
$22K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,384 |
6,497 |
$22K |
| 85027 |
|
4,545 |
3,574 |
$21K |
| 86803 |
|
1,716 |
1,560 |
$21K |
| 88304 |
|
761 |
684 |
$20K |
| 70486 |
|
70 |
65 |
$19K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
6,795 |
4,128 |
$19K |
| 73110 |
|
311 |
282 |
$18K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
6,671 |
5,395 |
$18K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
570 |
555 |
$18K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
394 |
308 |
$17K |
| 87081 |
|
4,096 |
3,805 |
$17K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
567 |
553 |
$16K |
| 84703 |
|
3,670 |
3,363 |
$16K |
| 82948 |
|
3,782 |
2,200 |
$16K |
| 82150 |
|
4,263 |
3,704 |
$16K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,787 |
2,133 |
$15K |
| 84425 |
|
728 |
711 |
$15K |
| 81003 |
|
6,717 |
6,000 |
$14K |
| 72131 |
|
59 |
52 |
$14K |
| 95806 |
|
131 |
111 |
$14K |
| J2060 |
Injection, lorazepam, 2 mg |
1,279 |
918 |
$13K |
| 97113 |
|
247 |
87 |
$13K |
| 76641 |
|
142 |
129 |
$13K |
| 83540 |
|
2,410 |
2,307 |
$13K |
| 87186 |
|
2,222 |
1,809 |
$13K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,343 |
1,504 |
$13K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
209 |
194 |
$13K |
| 83655 |
|
1,045 |
1,030 |
$13K |
| 87040 |
|
1,810 |
1,612 |
$13K |
| 85379 |
|
2,352 |
2,157 |
$12K |
| 86328 |
|
369 |
329 |
$12K |
| 72100 |
|
202 |
175 |
$12K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
13 |
13 |
$10K |
| 80320 |
|
766 |
668 |
$10K |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
895 |
668 |
$10K |
| 86905 |
|
100 |
90 |
$10K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
37 |
35 |
$10K |
| 95811 |
|
15 |
13 |
$10K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
1,471 |
1,186 |
$10K |
| 83605 |
|
1,591 |
1,385 |
$9K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
3,521 |
2,705 |
$9K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
27 |
27 |
$9K |
| 93225 |
|
140 |
123 |
$9K |
| 85610 |
|
3,269 |
2,762 |
$8K |
| 87070 |
|
1,642 |
1,210 |
$8K |
| 88307 |
|
148 |
105 |
$8K |
| 83970 |
|
272 |
219 |
$8K |
| A9270 |
Non-covered item or service |
6,770 |
2,511 |
$8K |
| 83001 |
|
352 |
337 |
$7K |
| 83550 |
|
1,053 |
996 |
$7K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
13 |
13 |
$7K |
| 86850 |
|
1,826 |
1,546 |
$7K |
| 87506 |
|
56 |
47 |
$7K |
| 80143 |
|
682 |
617 |
$7K |
| 74021 |
|
100 |
81 |
$7K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,002 |
543 |
$7K |
| 80179 |
|
664 |
604 |
$7K |
| 93226 |
|
117 |
107 |
$7K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,078 |
1,398 |
$6K |
| 85730 |
|
1,742 |
1,574 |
$6K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
929 |
394 |
$6K |
| 87807 |
|
947 |
896 |
$6K |
| 12001 |
|
102 |
88 |
$6K |
| 73080 |
|
57 |
55 |
$6K |
| 82550 |
|
806 |
700 |
$6K |
| 82570 |
|
1,160 |
1,063 |
$5K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
14 |
13 |
$5K |
| 86038 |
|
517 |
483 |
$5K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
2,979 |
1,912 |
$5K |
| 82248 |
|
1,127 |
1,073 |
$5K |
| 82784 |
|
483 |
429 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
405 |
357 |
$5K |
| 83516 |
|
286 |
269 |
$5K |
| 93971 |
|
25 |
25 |
$5K |
| 84481 |
|
302 |
279 |
$5K |
| 74220 |
|
43 |
39 |
$5K |
| 86592 |
|
1,330 |
1,237 |
$5K |
| 82670 |
|
194 |
187 |
$4K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
13 |
13 |
$4K |
| 80055 |
|
78 |
77 |
$4K |
| 84550 |
|
980 |
894 |
$4K |
| 73221 |
|
12 |
12 |
$3K |
| 75574 |
|
14 |
12 |
$3K |
| 71271 |
|
36 |
30 |
$3K |
| 94726 |
|
82 |
77 |
$3K |
| 84436 |
|
835 |
796 |
$3K |
| 83525 |
|
226 |
223 |
$3K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
343 |
314 |
$3K |
| 85652 |
|
1,323 |
1,212 |
$3K |
| 84146 |
|
187 |
173 |
$3K |
| 86901 |
|
2,222 |
1,887 |
$3K |
| 94729 |
|
83 |
78 |
$3K |
| 97035 |
|
250 |
88 |
$3K |
| 76536 |
|
24 |
24 |
$3K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
264 |
198 |
$3K |
| 88112 |
|
69 |
65 |
$3K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
742 |
668 |
$3K |
| 97116 |
|
113 |
64 |
$3K |
| 90715 |
|
189 |
176 |
$3K |
| 87340 |
|
665 |
626 |
$3K |
| 80074 |
|
76 |
64 |
$3K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
15 |
13 |
$3K |
| 86787 |
|
122 |
118 |
$2K |
| 86738 |
|
311 |
293 |
$2K |
| 86757 |
|
90 |
88 |
$2K |
| C9113 |
Injection, pantoprazole sodium, per vial |
1,096 |
554 |
$2K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
415 |
301 |
$2K |
| 83921 |
|
205 |
96 |
$2K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
595 |
266 |
$2K |
| 86762 |
|
456 |
437 |
$2K |
| Q9961 |
High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml |
104 |
83 |
$2K |
| 87205 |
|
637 |
481 |
$2K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
147 |
116 |
$2K |
| 86618 |
|
109 |
89 |
$2K |
| 86769 |
|
30 |
27 |
$2K |
| 87046 |
|
212 |
103 |
$1K |
| 72050 |
|
17 |
13 |
$1K |
| J3480 |
Injection, potassium chloride, per 2 meq |
326 |
159 |
$1K |
| 73502 |
|
43 |
37 |
$1K |
| J1335 |
Injection, ertapenem sodium, 500 mg |
32 |
24 |
$1K |
| 72114 |
|
15 |
12 |
$1K |
| 74022 |
|
24 |
24 |
$1K |
| 87324 |
|
169 |
154 |
$1K |
| 86666 |
|
71 |
71 |
$1K |
| 76870 |
|
12 |
12 |
$970.36 |
| 82043 |
|
192 |
180 |
$966.39 |
| 90714 |
|
126 |
111 |
$932.74 |
| A9537 |
Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries |
58 |
54 |
$922.95 |
| 97804 |
|
12 |
12 |
$920.78 |
| 87209 |
|
87 |
83 |
$915.07 |
| 87427 |
|
105 |
101 |
$914.00 |
| 71101 |
|
13 |
13 |
$870.85 |
| 86003 |
|
14 |
12 |
$851.61 |
| 86308 |
|
240 |
232 |
$797.90 |
| 97012 |
|
35 |
13 |
$772.34 |
| 82565 |
|
96 |
91 |
$737.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
129 |
121 |
$730.02 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
289 |
241 |
$675.01 |
| 82378 |
|
31 |
25 |
$623.97 |
| 84165 |
|
45 |
43 |
$614.80 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
69 |
65 |
$600.01 |
| 87045 |
|
106 |
102 |
$596.69 |
| 88302 |
|
24 |
16 |
$594.51 |
| 87177 |
|
89 |
83 |
$586.74 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
15 |
12 |
$563.88 |
| 82140 |
|
103 |
52 |
$498.90 |
| 84520 |
|
65 |
64 |
$474.83 |
| 86037 |
|
15 |
15 |
$468.78 |
| J1644 |
Injection, heparin sodium, per 1000 units |
55 |
38 |
$445.62 |
| 86696 |
|
27 |
27 |
$443.10 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
132 |
93 |
$437.45 |
| 87329 |
|
88 |
84 |
$420.63 |
| 74300 |
|
12 |
12 |
$407.10 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
352 |
260 |
$404.42 |
| 86695 |
|
27 |
27 |
$396.09 |
| 86671 |
|
14 |
14 |
$325.90 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
94 |
82 |
$294.10 |
| 84144 |
|
14 |
14 |
$281.44 |
| 88104 |
|
13 |
12 |
$239.06 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
62 |
44 |
$227.10 |
| 82947 |
|
44 |
32 |
$226.45 |
| 84156 |
|
71 |
64 |
$204.74 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
22 |
15 |
$170.25 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
25 |
24 |
$164.78 |
| 86430 |
|
35 |
33 |
$162.76 |
| C1769 |
Guide wire |
17 |
14 |
$158.09 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
111 |
88 |
$145.65 |
| 84100 |
|
34 |
29 |
$136.98 |
| 89055 |
|
34 |
30 |
$84.76 |
| 83615 |
|
13 |
12 |
$81.37 |
| 80329 |
|
76 |
67 |
$51.60 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
26 |
15 |
$45.19 |
| 80050 |
General health panel |
18 |
17 |
$44.93 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
52 |
42 |
$33.78 |
| 84155 |
|
57 |
55 |
$26.55 |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
19 |
12 |
$15.87 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
46 |
38 |
$15.14 |